By Lynda Williams, medwireNews Reporter
medwireNews: Artificial intelligence can expedite assessment of tumour-infiltrating lymphocytes and immune phenotype identification in resected pancreatic ductal adenocarcinoma, research demonstrates.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
Read the full story on the L’Institut Servier website
Image credit: © Matthieu / stock.adobe.com
